Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Velpatasvir/Sofosbuvir in HIV/HCV Coinfection
NCT03250910Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir + velpatasvir in hepatitis C (HCV), sponsored by National Taiwan University Hospital. Started Aug 2016; status: completed.
02
Drugs
sofosbuvir + velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03250910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03250910.